Pharmacokinetics of Neostigmine and Glycopyrrolate
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
A group of 6 able-bodied healthy volunteers will receive Neostigmine (NEO) and Glycopyrrolate
(GLY) intravenously and via 2 methods of Iontophoresis (ION): one-patch and two-patch
administration, with subsequent blood draws over 1 hour in order to measure the
pharmacokinetic behavior of the drugs in-vivo.